Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for P3 Health Partners Inc. (PIII:NASDAQ), powered by AI.
P3 Health Partners Inc. is currently trading at $11.29. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for P3 Health Partners Inc. on Alpha Lenz.
P3 Health Partners Inc.'s P/E ratio is -0.2.
“P3 Health Partners Inc. trades at a P/E of -0.2 (undervalued) with strong ROE of 373.2%. 3Y revenue CAGR of 11.6% highlights clear growth momentum.”
Ask for details →P3 Health Partners Inc. is a healthcare company focused on transforming the primary care landscape across the United States. This organization is dedicated to improving patient outcomes by providing high-quality, coordinated care that emphasizes preventative measures. P3 Health Partners primarily works within the Medicare Advantage space, serving senior communities with a comprehensive approach that integrates clinical services, wellness programs, and customer-focused technology solutions. The company collaborates closely with physicians and healthcare providers to align care delivery with value-based care models, striving to reduce hospital admissions and improve overall patient satisfaction. By leveraging advanced analytics and data-driven insights, P3 Health Partners aims to achieve better healthcare outcomes at reduced costs. As the demand for efficient, patient-centric healthcare systems continues to grow, P3 Health Partners plays a crucial role in enhancing healthcare efficiency and accessibility, making it an important player in the evolving healthcare market.
“P3 Health Partners Inc. trades at a P/E of -0.2 (undervalued) with strong ROE of 373.2%. 3Y revenue CAGR of 11.6% highlights clear growth momentum.”
Ask for details →P3 Health Partners Inc. (ticker: PIII) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 360 employees. Market cap is $37M.
The current price is $11.29 with a P/E ratio of -0.25x and P/B of -0.24x.
ROE is 373.15% and operating margin is -18.53%. Annual revenue is $1.5B.